John Russell

John Russell serves as the Executive Chairman of the Board at Ultromics since March 2023 and as an Operating Partner at Revival Healthcare Capital since May 2022, focusing on the medical device and diagnostic sectors. Previously, John held the positions of President, CEO, and Board Member at Cardiva Medical, Inc. until its acquisition by Haemonetics in March 2021, and President, CEO, and Board Member at Corventis, Inc. prior to its acquisition by Medtronic in 2014. John’s extensive career includes prominent roles at Boston Scientific and Guidant Corporation, where responsibilities spanned various sales and management positions in cardiac rhythm management. Early career experience includes roles at Eli Lilly and Edwards Lifesciences. John Russell holds a Bachelor of Science in Mechanical Engineering and Materials Science from Duke University and an MBA from the University of North Carolina at Chapel Hill.